earnings
confidence high
sentiment neutral
materiality 0.70
MariMed Q4 revenue up 15.5% YoY to $35.8M; net income turns positive but EBITDA margin shrinks
MARIMED INC.
2022-FY EPS reported
$0.04
revenue$134,010,000
- Q4 revenue $35.8M (+15.5% YoY); full-year revenue $134.0M (+10.3% YoY).
- GAAP net income Q4 $4.8M vs loss of $6.4M in prior year; full-year net income $13.6M (+79% YoY).
- Non-GAAP adjusted EBITDA Q4 $4.5M (down 46% YoY); full-year $32.4M (down 24% YoY).
- GAAP gross margin Q4 44% vs 50% prior year; full year 48% vs 55%.
- CEO: positive cash flow from ops for third consecutive year; expects accelerated growth in 2023.